PRESS RELEASE Eli Lilly Italy: a new €750 million pact with Italy by 2025
Lilly's manufacturing site in the Sesto Fiorentino area is one of the largest and most innovative biotechnology drug manufacturing facilities in Italy and one of the largest within Eli Lilly's global manufacturing network.
Tags in this Article:
No categories
Related articles
Alcobendas at 35: the recipe for success in R&D
Even though Lilly’s R&D centre in Alcobendas only opened in 2002, R&D activity began at the site 35 years ago. The resilience and creativity of the highly qualified team of researchers who began operations allowed the company to build an R&D site that would go on to employ one hundred scientists.